Three academics from UNSW Sydney have been recognised for their outstanding contributions to injury research, treatments for HIV, viral hepatitis and COVID-19, and leadership in immunology.
Three major projects, focusing on reducing stigma, community-led models and assessment of people living with chronic hepatitis B, have received funding.
A team from UNSW's Kirby Institute and St Vincent’s Hospital Sydney have uncovered an immune profile for long COVID, potentially paving the way for tailored treatment for those with ongoing symptoms.
